Metraipolis › archive › dc_bbb8f561197f
Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience — Europe PMC PMID:42394926
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42394926
- DOI
- 10.3389/fneur.2026.1830276
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:38:57.898Z
- SHA-256 of the archived text
14c6bdeb507b77ee64d57463fd8bea99341e26b77c6e5cf05c45969ad3e815b8- Stable URL of this page
https://metraipolis.com/documento/dc_bbb8f561197f
How to cite
Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience — Europe PMC PMID:42394926 — Europe PMC (en), https://europepmc.org/article/MED/42394926 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbb8f561197f (Metraipolis archive dc_bbb8f561197f, sha256 14c6bdeb507b77ee64d57463fd8bea99341e26b77c6e5cf05c45969ad3e815b8)
BibTeX
@misc{dcbbb8f561197f,
title = {Efficacy, tolerability and barriers to the use of anti-CGRP medications among migraine patients in Egypt: real world experience — Europe PMC PMID:42394926},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42394926},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbb8f561197f; sha256 14c6bdeb507b77ee64d57463fd8bea99341e26b77c6e5cf05c45969ad3e815b8},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42394926. Agents can read the archived copy with the MCP tool read_document.